Aggregator
White House rolls out AI funding — and signals a new era for US science
Bizarre CRISPR enzyme kills cancer cells by shredding their DNA
Author Correction: Feature-specific threat coding in lateral septum guides defensive action
Briefing Chat: Baby <i>T. rex</i> were killers from birth, suggest new fossils
Personalized gene therapy relieves severe epilepsy in two boys
APOE2 may protect the brain from Alzheimer’s and aging
The longevity-linked APOE2 gene appears to protect brain cells by reducing DNA damage and helping neurons recover from stress. The finding could open a new path toward treatments that mimic APOE2’s defenses in people at higher genetic risk for Alzheimer’s.
Ozempic and Mounjaro linked to a surprising hair loss risk
A large study suggests that GLP-1 drugs including Ozempic and Mounjaro may slightly increase the risk of hair loss in people with type 2 diabetes. Compared with two other common classes of diabetes medications, GLP-1 users had a significantly higher rate of alopecia, though the absolute risk was still low. The hair loss was mainly non-scarring, which means it may be reversible.
Major genetic breakthrough reveals hidden causes of severe morning sickness in pregnancy
A massive genetic study has identified nine new genes linked to hyperemesis gravidarum, the most severe form of pregnancy sickness, bringing the total number of known risk genes to ten. The discoveries provide fresh insight into why some women experience debilitating nausea and vomiting during pregnancy while others do not. Several of the newly identified genes are involved in appetite, nausea, metabolism, and brain function, opening the door to more targeted treatments.
This drug could help end the HIV epidemic. Its rollout has hit speed bumps
One shot of lenacapavir can protect for 6 months—but aid cuts and uncertain demand mean little drug has reached the countries that most need it
FDA committee votes to make peptides more widely available
The loosely regulated molecules could soon become easier to buy, despite unknowns about their risks
A healthier global diet could cut farm emissions by 85%
A global shift toward healthier diets could sharply reduce livestock farming, free up agricultural land, and cut emissions from land-use change by 85% by 2050. At the same time, fruit, vegetable, nut, and legume production could soar, creating a sweeping transformation of what the world grows and eats.
Popular childhood drinks may raise blood pressure decades later
A 25-year study found that frequent consumption of soda, sports drinks, and fruit juice beginning in childhood was linked to a higher risk of high blood pressure in adulthood. Swapping one daily drink for whole fruit, milk, or water could significantly reduce that risk.
Integrated identification and validation of HSP90AA1 as a therapeutic target of Astragalus membranaceus in Alzheimer's disease
Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder lacking effective disease-modifying therapies. Astragalus membranaceus (AM) has shown potential neuroprotective effects, but its underlying mechanisms remain incompletely understood. In this study, a meta-analysis, network pharmacology, molecular simulation, and experimental validation were integrated to investigate the therapeutic potential of AM in AD. Meta-analysis of three randomized controlled trials showed that AM...
Early detection of Alzheimer's disease with circular RNA from blood
No abstract
A biomimetic hybrid membrane vesicle nanoplatform attenuates tendinopathy through neuroinflammation modulation and tendon regeneration
Tendinopathy is a common condition that causes long-term pain. The inflammatory microenvironment (inflamed soil) promotes the ingrowth of sensory nerves (a key pain trigger) and induces functional impairments in tendon stem/progenitor cells (TSPCs) (dysfunctional seeds). These interconnected processes collectively drive the progression of tendinopathy, which is frequently accompanied by persistent pain. Here, we develop a multifunctional nanoplatform (MSM-DTM) by integrating macrophage-sensory...
Single-cell resolution of skeletal muscle aging: Current paradigms and perspectives
Skeletal muscle aging is a complex biological process that involves coordinated changes in multiple cell types. Recent breakthroughs in single-cell sequencing technology have provided new perspectives regarding this process. Here, we systematically summarize current progress in single-cell technology with respect to skeletal muscle aging. We focused on specific molecular characteristics and interaction networks of muscle fiber, satellite and immune cells during aging. Aging skeletal muscles...
From binary senescence to state-resolved senotherapy in cancer: therapeutic windows from heterogeneity
Tumor senescence is a durable cell-cycle arrest triggered by oncogenic signalling, DNA damage and therapeutic stress. Although senescence can restrain malignant expansion, heterogeneous senescence-associated secretory programs can also promote tumor progression, immune evasion and treatment resistance. Crucially, the composition, magnitude and persistence of these secretory programs vary across cell types, microenvironmental niches and treatment phases, making binary detection of "senescent...
The cardiac 4D nucleome: nuclear and chromatin dynamics across development, disease and ageing
The nucleus is a highly organized and dynamic organelle, with hierarchical layers ranging from nucleosome positioning to chromatin domains and higher-order 3D genome topology. Viewed over time as the 4D nucleome, this organization enables precise and context-dependent transcriptional control. In the heart, dynamic nuclear architecture orchestrates precise transcriptional programmes that control lineage commitment and the establishment of cardiac cell types crucial not only for heart development,...
Alzheimer's trial results lend momentum to drugs targeting tau
First drug to lower the protein and slow cognitive decline created buzz despite puzzling data.
Single-cell multiomics connects 3D genome and transcriptome alterations in Alzheimer's disease
Alzheimer's disease (AD) disrupts brain function through cell type-specific transcriptomic and epigenomic alterations, yet the contribution of three-dimensional (3D) genome organization to AD remains poorly understood. We applied GAGE-seq (genome architecture and gene expression by sequencing) to jointly profile gene expression and 3D chromatin structure in single cells from postmortem brain tissue from AD patients and age-matched individuals without AD, revealing chromatin reorganization linked...